Christopher M. Smith - Feb 23, 2024 Form 4 Insider Report for NEOGENOMICS INC (NEO)

Role
Chief Executive Officer
Signature
/s/ Ali Olivo, Attorney-in-Fact
Stock symbol
NEO
Transactions as of
Feb 23, 2024
Transactions value $
$0
Form type
4
Date filed
2/27/2024, 04:28 PM
Previous filing
Jun 8, 2023
Next filing
May 14, 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
holding NEO Common Stock 602K Feb 23, 2024 Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction NEO Stock Option (Right to Buy) Award $0 +288K $0.00 288K Feb 23, 2024 Common Stock 288K $16.45 Direct F6
transaction NEO Restricted Stock Unit Award $0 +172K $0.00 172K Feb 23, 2024 Common Stock 172K $0.00 Direct F4, F7
transaction NEO Performance Stock Unit Award $0 +172K $0.00 172K Feb 23, 2024 Common Stock 172K $0.00 Direct F4, F8
holding NEO Stock Option (Right to Buy) 694K Feb 23, 2024 Common Stock 694K $12.62 Direct F1
holding NEO Stock Option (Right to Buy) 270K Feb 23, 2024 Common Stock 270K $19.65 Direct F2
holding NEO Restricted Stock Unit 144K Feb 23, 2024 Common Stock 144K $0.00 Direct F3, F4
holding NEO Performance Stock Unit 144K Feb 23, 2024 Common Stock 144K $0.00 Direct F4, F5
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 On August 15, 2022, Mr. Smith was granted 694,444 stock options. These options vest ratably over the first four anniversary dates of the grant date.
F2 On May 11, 2023, Mr. Smith was granted 269,841 stock options. These options vest ratably over the first three anniversary dates of the grant date.
F3 On May 11, 2023, Mr. Smith was granted 144,190 restricted stock units. These restricted stock units vest ratably over the first three anniversary dates of the grant date.
F4 Once vested, the shares of common stock are not subject to expiration.
F5 On May 11, 2023, Mr. Smith was granted 144,190 performance stock units representing the number of shares that may vest at target performance. The maximum number of shares that may vest pursuant to the performance criteria is 216,285. The number of performance stock units that may vest is based on the achievement of certain share growth goals based on the weighted average price of the Company's common stock over the 20-day trailing trading period at the applicable measurement dates, subject to continued service with the Company.
F6 On February 23, 2024, Mr. Smith was granted 287,940 stock options. These options vest ratably over the first three anniversary dates of the grant date.
F7 On February 23, 2024, Mr. Smith was granted 172,239 restricted stock units. These restricted stock units vest ratably over the first three anniversary dates of the grant date.
F8 On February 23, 2024, Mr. Smith was granted 172,240 performance stock units representing the number of shares that may vest at target performance. The maximum number of shares that may vest pursuant to the performance criteria is 258,360. 50% of the number of performance stock units that may vest is based on the achievements of certain share growth goals based on the weighted average price of the Company's common stock over the 20-day trailing trading period at the applicable measurement dates, subject to continued service with the Company. 50% of the number of performance stock units that may vest is based on the achievement of certain revenue growth goals based on the achievement of the cumulative fiscal year revenue goal at the applicable measurement amounts, subject to continued service with the Company.